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Abstract
Background: In natural cycles, women conceive when intercourse takes place during a six-day period ending on
the day of ovulation. The current practice in intrauterine insemination (IUI) cycles is to perform the IUI 24-36 hours
after the hCG administration, when the ovulation is already imminent. In this study hCG was administered after the
IUI, which more closely resembles the fertilisation process in natural cycles.
Methods: All the IUIs performed since the beginning of 2007 were analysed retrospectively. Our standard protocol
has been to perform the IUI 24-32 hours after hCG administration. From the end of 2008, we started to inject hCG
after the IUI at random. The main outcome measure was the result of a urinary pregnancy test. Generalized
Estimating Equations (GEE) was used to identify independent factors affecting the cycle outcome.
Results: The analysis included 228 cycles with hCG administered before and 104 cycles hCG administered after the
IUI. The pregnancy rates were 10.9% and 19.6% (P = 0.040), respectively. Independent factors (OR, 95% CI) affecting
the cycle outcome were sperm count (2.65, 1.20-5.81), number of follicles > 16 mm at IUI (2.01, 1.07-3.81) and the
time of hCG administration (2.21, 1.16-4.19).
Conclusion: Improved pregnancy rate was observed with administration of hCG after IUI.
Background
Intrauterine insemination (IUI) is a common treatment.
The pregnancy rate in IUI cycles with partners’ sperm
has varied between 11.4% and 12.6% during 2001-2004
in Europe [1] and the multiple birth rate between 11.2%
and 13.1%. As reported by the ESHRE Capri Workshop
Group on IUI [1], despite the use of clomiphene/gona-
dotrophins to induce multiovulation and the preparation
of the semen sample, the pregnancy rates in IUI cycles
are not significantly better than the results achieved
after ordinary or timed intercourse. In fact, IUI has not
been classified as an assisted reproductive technique
(ART) despite its wide use [2].
The ESHRE Capri Workshop Group wanted to clarify
the role of individual topics in the effectiveness of IUI
treatment. One of the topics was the timing of the inse-
mination. Accordingly, in the majority of the studies
included in the analysis, the insemination was per-
formed 32-36 hours after hCG administration [1]. How-
ever, it appears that among healthy women, the best
chance to become pregnant is if intercourse occurs up
to six days before ovulation [3]. If this is applied to the
IUI protocol, the hCG should be injected after the inse-
mination rather than before it. In this study we wanted
to evaluate the effect of postponing the hCG injection
until after IUI.
Methods
Subjects
We analysed the data on IUI cycles carried out between
January 2007 and September 2009 at the Department of
Obstetrics and Gynaecology, Oulu University Hospital,
Oulu, Finland. In all of these cycles, a clomiphene
citrate/FSH/hCG stimulation protocol and a standard
IUI technique with partner’s sperm were used.
The study couples had at least 1 year of infertility and
had undergone a basic infertility evaluation consisting of
anamnesis, semen analysis using WHO guidelines and
hysterosonosalpingography. Prolactin and TSH concen-
trations were assessed if the menstrual period was irre-
gular and polycystic ovarian syndrome was not
observed. The upper age limit for the treatment was 40
years. IUI was the first treatment offered and it was
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severe oligospermia or bilateral tubal patency. If this
proved unsuccessful, we continued with controlled ovar-
ian hyperstimulation and IVF/ICSI.
Ovarian stimulation
All women in the study underwent ovarian stimulation
using clomiphene citrate and FSH. They were given 50-
100 mg of clomiphene citrate on cycle days 3 to 7, fol-
lowed by 75-150 IU FSH daily. Ovarian and endometrial
responses were monitored by vaginal ultrasonography
on cycle days 9 to 12. IUI was then scheduled at the
p o i n tw h e ni tw a se s t i m a t e dt h a tt h el a r g e s tf o l l i c l e s
would have reached 17-18 mm in diameter. If more
than three follicles > 16 mm existed at the time of IUI,
the excessive follicles were either emptied or the cycle
was abandoned. The abandoned cycles were not
included in the analysis. IUI was performed even when
the follicles had already been ruptured by the time of
IUI.
Sperm preparation and intrauterine insemination
Semen samples were collected by masturbation after 2-4
days of sexual abstinence. After liquefaction and initial
sperm analysis, the standard gradient centrifugation
technique was used for preparation, employing Sperm-
Grad™ gradient material in G-IVF™ Plus-medium (Vitro-
life Ab, Gothenburg, Sweden).
Intrauterine insemination was performed using an
intrauterine catheter with a 1-ml syringe. The catheter
was passed through the cervical canal and the sperm
suspension expelled into the uterine cavity. Insemination
volume was 0.5 ml. The women remained supine for 5-
10 min after IUI.
Timing of hCG injection
The standard protocol in our unit has been to inject
hCG (5000 IU) when at least one follicle has reached 17
mm in mean diameter. The hCG was injected in the
morning and the IUI was performed next day, 24-32
hours after the administration of hCG. We have not
requested patients to wake up during night-time for the
injection, since there seems to be no difference in the
pregnancy rate in IUls performed at 24 hours versus 36
hours after hCG [4]. All patients in 2007 and the major-
ity of those in 2008 were treated according to this pro-
tocol. From the end of 2008, we started to give the hCG
injection 3-5 minutes after IUI procedure. The IUI pro-
cedure was performed when the largest follicle had
reached 17 mm in diameter. No randomisation in the
timing of hCG injection was performed at any time in
this pilot study. The vast majority of patients treated in
2009 had the hCG injection after the IUI. No luteal sup-
port was given to any of the patients. If menstruation
was delayed after IUI, a urinary pregnancy test was per-
formed. If the test was positive, a transvaginal ultrasono-
graphic examination was performed at pregnancy week
7. Clinical pregnancy was confirmed if intrauterine
gestational sac with heart beat was detected.
Statistical analysis
Differences between groups were tested using Student’s
tt e s ta n dt h ec
2 test. We used Generalized Estimating
Equations (GEE) to identify independent factors contri-
buting to the success (positive pregnancy test and clini-
cal pregnancy rate) of the IUI cycle. This model takes
into account that there may more than one observation
per patient. The factors selected for the analysis were
sperm count after preparation (× 10
6/ml), number of
follicles > 16 mm at IUI, the time of hCG injection,
male-factor and unexplained-infertility diagnosis and
cycle day of insemination. All the factors were treated as
dichotomous variables, except the cycle day of insemina-
tion, which was a continuous variable. The categories
for dichotomous variables were: sperm count < or ≥ 20
×1 0
6/ml; number of follicles 0-1 or 2-3; the time of
hCG injection either 24-32 h prior to IUI or just after
IUI; male-factor (either male or non-male) and unex-
plained infertility (either unexplained or non-unex-
plained). The selected cut-off points for sperm count
and number of follicles were arbitrarily chosen. GEE
was performed using the SPSS 16.0 for Mac (SPSS, Chi-
cago, IL). The chosen level of significance was P < 0.05.
Results
The statistical analysis consisted of 332 intrauterine
inseminations. There were 99 patients who had two
inseminations and 134 who had only one insemination.
The urinary pregnancy test yielded a positive result in
45 cycles, giving a pregnancy rate of 13.6%. The clinical
pregnancy rate was 12.3%. In 25 out of 332 cycles
(7.5%) all the follicles were already ruptured at the time
of insemination; the urinary pregnancy test became
positive in four cycles.
There were differences between those who conceived
and who did not (Table 1.). Those who conceived were
more likely to have unexplained infertility and less likely
to have male factor as the main diagnosis. A sperm
count ≥ 20 × 10
6/ml after preparation and a tendency
to have 2-3 follicles at IUI were more typical in women
who became pregnant. In addition, hCG was injected
more frequently after IUI in patients with a positive
pregnancy test (Table 1.).
HCG administration before vs. after IUI
There were 228 inseminations where the hCG was
injected 24-32 h before the IUI and 104 cycles where
the injection was done just after the IUI. The
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ferences in female age, main infertility diagnosis, sperm
count after preparation or number of follicles at the
time of insemination (Table 2.). The pregnancy rate was
10.9% when hCG was injected before and 19.6% when
hCG was injected after the IUI (P = 0.040). The clinical
pregnancy rates were 9.6% and 18.3% (P =0 . 0 3 2 ) ,
respectively.
Generalized estimating equations (GEE)
The aim of the GEE analysis here was to find indepen-
dent factors affecting the cycle outcome. Data for 322
cycles were available and included in the final model
(data of 10/332 cycles were incomplete). When the
response was positive pregnancy test, the independent
factors in the final model were sperm count, number of
follicles and the time of hCG injection (Table 3). Male
factor, unexplained infertility or the insemination cycle
day were not independent factors and were, therefore,
not included in the model. When the response was set
as clinical pregnancy, the independent factors were
sperm count and the time of hCG injection (Table 4.).
Discussion
Postponing the hCG administration until after the IUI
instead of injecting it 24-32 hours before IUI resulted in
a significantly increased pregnancy rate. The other inde-
pendent factors affecting the IUI cycle outcome in this
s t u d yw e r et h en u m b e ro ff o l l i c l e s>1 6m ma n dt h e
sperm count.
In most studies that have evaluated the outcome in
IUI cycles, the insemination has been performed 24-36
hours following hCG administration [1,4]. This practice
is based on data indicating that, in natural cycles, the
ovulation takes place 32 hours (range 24-56 hours) after
the onset of the luteinizing hormone (LH) surge [5],
whereas in stimulated cycles, it takes place approxi-
mately 36-38 hours after the hCG injection [6]. As the
Table 1 Comparison of characteristics between those who tested positive and negative in urinary pregnancy test.
Preg. test + (n = 45) Preg. test - (n = 287) P
Age (SD) in years 29.8 (5.1) 30.1 (4.3) NS
Main diagnosis
Unexplained 65.9% 47.3% 0.024
Male factor 6.8% 18.8% 0.053
Endometriosis 4.5% 8.7% NS
Hormonal 13.6% 17.7% NS
Multiple 4.5% 6.5% NS
Sperm count ≥ 20 × 10
6/ml after preparation 80.0% 61.1% 0.019
Total FSH consumption (SD) 155 IU (58) 160 IU (91) NS
2-3 follicles at insemination 64.4% 49.1% 0.076
Cycle day of insemination (SD) 13.7 (1.7) 13.8 (1.6) NS
hCG injection after IUI 46.7% 28.9% 0.024
Table 2 Comparison of characteristics in patients with different timing in hCG injection
hCG injection 24-32 h before IUI
(n = 228)
hCG injection after IUI
(n = 104)
P
Age (SD) in years 30.3 (4.4) 29.5 (4.5) NS
Main diagnosis
Unexplained 50.2% 50.0% NS
Male factor 17.6% 16.7% NS
Endometriosis 6.8% 10.2% NS
Hormonal 16.7% 17.6% NS
Multiple 7.2% 3.7% NS
Sperm count ≥ 20 × 10
6/ml after preparation (SD) 65.5% 62.2% NS
Total FSH consumption (SD) 163 IU (98) 152 IU (58) NS
Number of follicles >16 mm at insemination (SD) 1.5 (0.8) 1.6 (0.7) NS
2-3 follicles at insemination 50.0% 53.2% NS
Cycle day of insemination (SD) 13.9 (1.7) 13.5 (1.3) 0.014
Positive urinary pregnancy test 10.9% 19.6% 0.040
Clinical pregnancy rate 9.6% 18.3% 0.032
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only 12-16 hours [7] and the spermatozoa survive only
for a limited period of time in the female reproductive
tract [8-10], it is rational to schedule the insemination
to the time of expected ovulation, i.e., 24-36 hours after
the administration of hCG.
In 1995, Wilcox et al. published a study of 221 healthy
women who were planning to become pregnant [3].
After stopping birth-control methods, the women col-
lected daily urine specimens and kept daily records of
their sexual intercourses. Oestrogen and progesterone
metabolites were measured from the urine samples to
estimate the day of ovulation. The authors observed that
conception occurred only when intercourse took place
during a six-day period that ended on the estimated day
of ovulation [3]. This finding suggests that the chances
to conceive in the natural cycle diminish considerably
after ovulation and that, preferably, the spermatozoa
should be available in the reproductive tract before ovu-
lation occurs. It also suggests that spermatozoa may sur-
vive for several days after intercourse, as women whose
last intercourse took place 5-6 days before ovulation did
conceive.
The results of the study by Wilcox et al. (1995) do not
totally support the current practice in IUI that hCG
should be administered before the insemination but
rather that it should be injected after the insemination.
In our study, we observed an increase of 80% in preg-
n a n c yr a t eb yp o s t p o n i n gt h eh C Gi n j e c t i o na f t e rt h e
IUI. The change in hCG administration ensured that the
spermatozoa were already present in the reproductive
duct before ovulation took place, similar to the situation
in successful natural cycles [3]. Since sexual intercourse
was allowed a couple of days before the insemination
and also after it, spontaneous conception is possible
although unlikely, since all of the couples had at least
one year infertility even before the start of basic
investigations.
Our results also confirmed earlier findings that the
number of follicles > 16 mm [11] and sperm count [12]
are independent factors affecting the IUI cycle outcome.
Conclusion
Postponing the hCG administration until after the IUI
seems to increase considerably the pregnancy rate in
IUI cycles. Since our study was retrospective and only
limited number of outcomes were presented, the finding
needs to be confirmed in randomised controlled trials. If
the finding is confirmed, it may eventually lead to avoid-
ance of long-lasting, inconvenient and expensive ovarian
hyperstimulation and IVF/ICSI in some couples under-
going infertility treatment.
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